Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade

Oncogene
E LengyelD D Boyd

Abstract

The urokinase-type plasminogen activator receptor (u-PAR) facilitates extracellular matrix degradation in part by accelerating plasmin formation at the cell surface. We previously reported that u-PAR expression is elevated in colon cancer cell lines characterized by their in vitro invasive capacity. Since, u-PAR expression is increased by a variety of growth factors, which signal through the extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2), we determined if these mitogen-activated protein kinases (MAPKs) regulate u-PAR expression in two cultured colon cancer cell lines. An in-gel kinase assay showed that ERK1 activity was considerably higher in RKO cells, which display > or = 10(5) receptors/cell, than the GEO cells which have approximately 10(4) urokinase receptors per cell. The expression of either an ERK-inactivating phosphatase (CL100), or a kinase-defective ERK1, decreased the activity of a u-PAR promoter-driven CAT reporter in RKO cells. Immune complex kinase assays indicated that the constitutive ERK1 activity in RKO cells was largely a result of an activated MEK1. Further, treatment of RKO cells with a specific inhibitor (PD 098059) of MEK1 activation, which diminished ERK1 activity, reduced the amount of urok...Continue Reading

Citations

May 14, 1998·International Journal of Cancer. Journal International Du Cancer·J A Aguirre GhisoE Bal de Kier Joffé
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Patrizia RussoPatrick M O'Connor
Oct 1, 2003·Experimental Cell Research·Dong Keun JungJeung-Whan Han
Jul 17, 1999·European Journal of Biochemistry·J A Aguirre GhisoE B de Kier Joffè
Apr 7, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Heike Allgayer
Nov 4, 2015·Biochimica Et Biophysica Acta·Kamini Rakkar, Ulvi Bayraktutan
Nov 22, 2005·Journal of Surgical Oncology·L R Rudmik, A M Magliocco
Apr 18, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Heike Allgayer
Apr 15, 2010·Journal of Immunoassay & Immunochemistry·Andrea L Small-Howard, Holden Harris
Oct 25, 2003·Oncogene·Ann-Sofi Härmälä-BraskénJohn E Eriksson
Oct 11, 2016·Biomarkers in Cancer·Martin C BoonstraCornelis F M Sier
Jul 13, 2006·The Journal of Biological Chemistry·Rajesh R NairDouglas D Boyd
Sep 12, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick UrbanSerenella Eppenberger-Castori
Feb 16, 2006·Blood·Jennifer W MitchellLindsey A Miles
Aug 24, 1999·Molecular and Cellular Biology·T H HolmströmJ E Eriksson
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Denis Martin ScheweHeike Allgayer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.